Genprex is advancing its novel gene therapies for large patient populations with cancer and diabetes who currently have limited treatment options AUSTIN, Texas, March 23, 2023 /PRNewswire/ — Rodney Varner, CEO of Genprex, Inc. (“Genprex” or the “Company”) (Nasdaq: GNPX), a clinical-stage…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.